Cost-Effectiveness Analysis of PEG-rhG-CSF as Primary Prophylaxis to Chemotherapy-Induced Neutropenia in Women With Breast Cancer in China: Results Based on Real-World Data

医学 乳腺癌 发热性中性粒细胞减少症 中性粒细胞减少症 内科学 化疗 化疗方案 养生 粒细胞集落刺激因子 肿瘤科 外科 癌症
作者
Jie Zhao,Gaoxing Qiao,Yan Liang,Jia Li,Wei Hu,Xu Zuo,Junfang Li,Chenglong Zhao,Xiaojian Zhang,Shuzhang Du
出处
期刊:Frontiers in Pharmacology [Frontiers Media]
卷期号:12: 754366-754366 被引量:10
标识
DOI:10.3389/fphar.2021.754366
摘要

Background: Pegylated recombinant human granulocyte colony-stimulating factors (PEG-rhG-CSFs) are more commonly and widely used than recombinant human granulocyte colony-stimulating factors (rhG-CSFs) in preventing chemotherapy-induced neutropenia in patients with stage II-IV breast cancer. To reduce the financial burden on these patients, the corresponding medical insurance directory needs to be revised. Objectives: To evaluate the cost-effectiveness of PEG-rhG-CSF versus rhG-CSF in patients with stage II-IV breast cancer in central China. Methods: Two Markov models, a chemotherapy model and a post-chemotherapy model, were developed to study the effects and costs, with a time horizon of 12 weeks and 35 years, respectively. Cost and probability input data were primarily obtained from a retrospective real-world study conducted in five tertiary hospitals. Propensity score matching was adopted to overcome retrospective bias. Other parameters were extracted from literature as well as advice from clinical experts. Univariate and probabilistic sensitivity analyses were conducted. Results: In the first chemotherapy model, PEG-rhG-CSF was associated with fewer episodes of febrile neutropenia (FN) (N = 19 per 1000 patients treated), infections (N = 24 per 1000 patients treated) and deaths (N = 2 per 1000 patients treated), but higher costs (¥36 more per patient treated). The post-chemotherapy model indicated that PEG-rhG-CSF led to higher gains in quality-adjusted life years (QALYs) (11.695 versus 11.516) in comparison to rhG-CSF. Sensitivity analysis showed that the cost of PEG-rhG-CSF had the greatest impact on the incremental costs, and incremental QALYs were very sensitive to the risk of RDI <85%. The probability of PEG-rhG-CSF being cost-effective compared to rhG-CSF was 66% at the willingness to pay (WTP) thresholds of ¥72,371 per QALY gained. Conclusion: According to this economic evaluation based on real-world data, PEG-rhG-CSF may be considered as a more cost-effective strategy relative to rhG-CSF for stage II-IV breast cancer patients in central China. However, to reflect a national perspective, further evidence is needed using data from larger-scale studies.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
千寻发布了新的文献求助10
刚刚
Fulcher完成签到 ,获得积分10
刚刚
波奇朵朵完成签到,获得积分0
1秒前
FashionBoy的应助被星空采纳,获得10
1秒前
宛唐完成签到,获得积分10
1秒前
星辰大海的应助被cc采纳,获得10
1秒前
lily完成签到 ,获得积分10
1秒前
不想在雪山跳舞的印第安火把完成签到,获得积分10
1秒前
Jenny发布了新的文献求助10
1秒前
1秒前
思源的应助被mkl采纳,获得10
2秒前
2秒前
zzy完成签到,获得积分10
2秒前
wanci的应助被hbuiio采纳,获得10
2秒前
彭于晏的应助被美酒青丝采纳,获得10
2秒前
Watson完成签到,获得积分10
2秒前
3秒前
阿飞发布了新的文献求助10
3秒前
777完成签到,获得积分10
3秒前
3秒前
冷傲小猫咪完成签到 ,获得积分10
3秒前
4秒前
小点点cy_发布了新的文献求助10
4秒前
海纳百川完成签到,获得积分10
4秒前
Wu完成签到,获得积分10
4秒前
小米南瓜粥完成签到,获得积分10
5秒前
ding完成签到 ,获得积分10
5秒前
5秒前
xrwwww发布了新的文献求助10
5秒前
领导范儿的应助被CYJ采纳,获得10
5秒前
文艺的小刺猬完成签到,获得积分10
5秒前
hututu完成签到 ,获得积分10
6秒前
宋沅鸿发布了新的文献求助20
6秒前
6秒前
困困的栗子球完成签到 ,获得积分10
7秒前
7秒前
7秒前
体贴寒烟完成签到 ,获得积分10
7秒前
阿拉斯嘉完成签到,获得积分10
7秒前
7秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180488
求助须知:如何正确求助?哪些是违规求助? 9570485
关于积分的说明 21812623
捐赠科研通 7776592
什么是DOI,文献DOI怎么找? 3433286
关于科研通互助平台的介绍 2557522
邀请新用户注册赠送积分活动 2479162